Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Ross Stores, Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Ross Stores, Inc. trades at $230.5 (market cap $73.66B). The key difference: Ross Stores, Inc. is far larger — about 8.7× Hinge Health Inc. Class A Common Stock's market cap, and Ross Stores, Inc. pays a 0.77% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Ross Stores, Inc. for 48 Days on average.
| HNGE | ROST | |
|---|---|---|
Market Cap | $8.47B | $73.66B |
Volume | 1,624,526 | 1,784,732 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $255.23 |
52-Week Low | $31.17 | $155.21 |
Typical Hold Time | 0 Days | 48 Days |
Enterprise Value | $8.09B | $74.11B |
Dividend Yield | — | 0.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Ross Stores (ROST) trades at $225.68, down slightly by 0.07% on the day, with a bearish technical signal despite strong fundamental performance. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $2.66 exceeding the $1.95 estimate. Revenue growth continues with $21.13B in 2025, supported by store expansion initiatives and value-focused strategies that are attracting cost-conscious shoppers.
ROST presents a compelling investment case with 64% analyst buy ratings and a $274.14 consensus price target representing 22% upside potential. However, near-term technical weakness and competitive pressures in discount retail warrant caution. The stock's premium valuation at 27.29 P/E requires sustained earnings growth to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
